Byrna Technologies Inc. (NASDAQ:BYRN – Free Report) – Equities research analysts at B. Riley lifted their Q4 2024 earnings per share (EPS) estimates for shares of Byrna Technologies in a research report issued on Tuesday, December 10th. B. Riley analyst J. Van. Sinderen now expects that the company will earn $0.02 per share for the quarter, up from their prior estimate of $0.01. The consensus estimate for Byrna Technologies’ current full-year earnings is $0.19 per share.
Byrna Technologies (NASDAQ:BYRN – Get Free Report) last released its quarterly earnings results on Wednesday, October 9th. The company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.05. The business had revenue of $20.85 million for the quarter, compared to analysts’ expectations of $20.82 million. Byrna Technologies had a net margin of 3.12% and a return on equity of 5.58%.
Get Our Latest Stock Analysis on Byrna Technologies
Byrna Technologies Trading Down 0.6 %
NASDAQ BYRN opened at $24.67 on Friday. Byrna Technologies has a 12-month low of $5.36 and a 12-month high of $25.77. The firm’s fifty day simple moving average is $17.74 and its two-hundred day simple moving average is $13.89. The firm has a market capitalization of $561.44 million, a P/E ratio of 274.11 and a beta of 1.80.
Insider Buying and Selling at Byrna Technologies
In other news, CEO Bryan Ganz sold 5,495 shares of Byrna Technologies stock in a transaction on Friday, September 20th. The stock was sold at an average price of $17.41, for a total transaction of $95,667.95. Following the transaction, the chief executive officer now owns 432,564 shares in the company, valued at $7,530,939.24. The trade was a 1.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Lisa Wager sold 2,450 shares of the firm’s stock in a transaction on Wednesday, September 18th. The stock was sold at an average price of $17.01, for a total value of $41,674.50. Following the sale, the insider now directly owns 224,555 shares of the company’s stock, valued at approximately $3,819,680.55. This trade represents a 1.08 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,424 shares of company stock worth $183,104. Corporate insiders own 11.08% of the company’s stock.
Institutional Trading of Byrna Technologies
Institutional investors have recently added to or reduced their stakes in the stock. nVerses Capital LLC purchased a new position in Byrna Technologies during the 3rd quarter valued at about $34,000. Quest Partners LLC acquired a new position in shares of Byrna Technologies during the third quarter worth $46,000. Algert Global LLC purchased a new position in Byrna Technologies in the second quarter valued at $131,000. MetLife Investment Management LLC lifted its holdings in Byrna Technologies by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 10,756 shares of the company’s stock worth $183,000 after buying an additional 6,061 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Byrna Technologies by 17.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 20,016 shares of the company’s stock worth $200,000 after acquiring an additional 2,976 shares in the last quarter. Institutional investors and hedge funds own 25.46% of the company’s stock.
About Byrna Technologies
Byrna Technologies Inc, a non-lethal defense technology company, provides non-lethal alternative solutions for law enforcement and private security. The company offers handheld personal security devices and shoulder-fired launchers without the need for background check or firearm license; and projectiles including chemical irritant, kinetic, and inert rounds.
Further Reading
- Five stocks we like better than Byrna Technologies
- The 3 Best Retail Stocks to Shop for in August
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Health Care Stocks Explained: Why You Might Want to Invest
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Stock Market Index and How Do You Use Them?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Byrna Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Byrna Technologies and related companies with MarketBeat.com's FREE daily email newsletter.